The clinically approved drugs dasatinib and bosutinib induce anti-inflammatory macrophages by inhibiting the salt-inducible kinases
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The clinically approved drugs dasatinib and bosutinib induce anti-inflammatory macrophages by inhibiting the salt-inducible kinases
Authors
Keywords
-
Journal
BIOCHEMICAL JOURNAL
Volume 465, Issue 2, Pages 271-279
Publisher
Portland Press Ltd.
Online
2014-10-30
DOI
10.1042/bj20141165
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Protein kinase networks that limit TLR signalling
- (2014) Kristopher Clark BIOCHEMICAL SOCIETY TRANSACTIONS
- Leptin-Mediated Increases in Catecholamine Signaling Reduce Adipose Tissue Inflammation via Activation of Macrophage HDAC4
- (2014) Bing Luan et al. Cell Metabolism
- SIK2 Is Critical in the Regulation of Lipid Homeostasis and Adipogenesis In Vivo
- (2014) Jinyoung Park et al. DIABETES
- Rapid Amelioration of Hyperglycemia Facilitated by Dasatinib in a Chronic Myeloid Leukemia Patient with type 2 Diabetes Mellitus
- (2014) Keiko Ono et al. INTERNAL MEDICINE
- Role of the SIK2–p35–PJA2 complex in pancreatic β-cell functional compensation
- (2014) Jun-Ichi Sakamaki et al. NATURE CELL BIOLOGY
- Dasatinib inhibits proinflammatory functions of mature human neutrophils
- (2012) K. Futosi et al. BLOOD
- Topical administration of the pan-Src kinase inhibitors, dasatinib and LCB 03-0110, prevents allergic contact dermatitis in mice
- (2012) S.H. Jung et al. BRITISH JOURNAL OF DERMATOLOGY
- Macrophage plasticity and polarization: in vivo veritas
- (2012) Antonio Sica et al. JOURNAL OF CLINICAL INVESTIGATION
- PGE2 Induces Macrophage IL-10 Production and a Regulatory-like Phenotype via a Protein Kinase A-SIK-CRTC3 Pathway
- (2012) K. F. MacKenzie et al. JOURNAL OF IMMUNOLOGY
- Inhibition of Src kinase activity attenuates amyloid associated microgliosis in a murine model of Alzheimer’s disease
- (2012) Gunjan Dhawan et al. Journal of Neuroinflammation
- Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages
- (2012) K. Clark et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bruton's tyrosine kinase phosphorylates Toll-like receptor 3 to initiate antiviral response
- (2012) K.-G. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulatory macrophages: Setting the Threshold for Therapy
- (2011) Bryan D. Fleming et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Inflammatory links between obesity and metabolic disease
- (2011) Carey N. Lumeng et al. JOURNAL OF CLINICAL INVESTIGATION
- Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
- (2011) Theonie Anastassiadis et al. NATURE BIOTECHNOLOGY
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
- CREB and the CRTC co-activators: sensors for hormonal and metabolic signals
- (2011) Judith Y. Altarejos et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice
- (2010) Julien Bricambert et al. JOURNAL OF CLINICAL INVESTIGATION
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Dasatinib inhibits the secretion of TNF-α following TLR stimulation in vitro and in vivo
- (2009) Cara K. Fraser et al. EXPERIMENTAL HEMATOLOGY
- The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophils
- (2008) M. Kneidinger et al. BLOOD
- Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells
- (2008) L L Remsing Rix et al. LEUKEMIA
- Fasting glucose improvement under dasatinib treatment in an accelerated phase chronic myeloid leukemia patient unresponsive to imatinib and nilotinib
- (2008) M. Breccia et al. LEUKEMIA RESEARCH
- The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling
- (2008) Olga Ananieva et al. NATURE IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now